Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
deals
fda
3
×
life sciences
national blog main
alexion pharmaceuticals
boston
national top stories
4d molecular therapeutics
abbvie
acne
agenus
alnylam pharmaceuticals
amyotrophic lateral sclerosis (als)
astrazeneca
auris health
autoimmune disorders
avexis
bayer
biomx
bladder cancer
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
celgene
centers for medicare and medicaid services
complement system
detroit blog main
detroit top stories
dicerna pharamceuticals
drugs
What
disease
3
×
drug
3
×
medicines
pharma
pharmaceuticals
alternative
approved
autoimmune
bio
candidate
caught
causing
companies
deal
dicerna
digital
epidemic
expensive
eye
fatty
fda
frenzied
gene
growing
hepatitis
intended
known
lead
led
liver
merck
nash
news
pay
potential
producing
protein
ra
race
research
Language
unset
Current search:
fda
×
drug
×
disease
×
" boston blog main "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More